Safety of Mercury in Fillings Debated
Posted on: Thursday, 7 September 2006, 03:00 CDT
By ANDREW BRIDGES
WASHINGTON - Federal health officials want to know if a government report reasonably concludes that silver dental fillings aren't dangerous even though they expose patients to toxic mercury.
The Food and Drug Administration has asked a joint panel of experts to review the study, which looked at 34 recent research studies, and weigh in on whether it reflects current knowledge about the risks associated with the fillings.
The study found "no significant new information" that would change the FDA's determination that mercury-based fillings don't harm patients except in rare cases where they have allergic reactions.
Consumer groups opposed to the use of mercury in dentistry dispute that conclusion. The groups petitioned the FDA earlier in the week for an immediate ban on use of the cavity-filler in pregnant women.
Amalgam fillings, also called silver fillings, by weight are about 50 percent mercury, joined with silver, copper and tin. Dentists have used amalgam to fill cavities since the 1800s. Today, tens of millions of Americans receive mercury fillings each year. Amalgam use has begun to taper off, though, with many doctors switching to resin composite fillings that blend better with the natural coloring of teeth.
With amalgam fillings, mercury vapor is released when patients chew and brush their teeth. Significant levels of mercury exposure can cause permanent damage to the brain and kidneys. Fetuses and children are especially sensitive to its harmful effects.
Scientists have found that mercury levels in the blood, urine and body tissues rise the more mercury fillings a person has. However, even among people with numerous fillings, exposure levels are well below those known to be harmful, the FDA report said.
The two-day, joint meeting of FDA experts on dental products and neurology concludes Thursday.
---
On the Net:
Food and Drug Administration: http://www.fda.gov/
Source: Associated Press/AP Online
Related Articles
- Research and Markets: Health 2.0 and Telecare for the Elderly is Filling the Gap in the Electronic Patient Record System Market
- Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia
- GE Healthcare Receives FDA Clearance for CARESCAPE Patient Data Module for Mobile Patient Monitoring
- CellSearch(TM) Circulating Tumor Cell Kit Receives FDA Clearance for Monitoring Patients With Metastatic Breast Cancer
- FDA Approves Vectibix for Patients With Colorectal Cancer
- Raymedica(R) Receives FDA Approval to Initiate Patient Enrollment in the HydraFlex(TM) Nucleus Arthroplasty System(TM) Clinical Trial
- Tests Show Mercury at High Levels in the Air
- Savient's Puricase(R) (PEG-Uricase) Substantially Reduces and Sustains Lower Plasma Urate Levels in Patients With Treatment-Resistant Gout
- Aranesp Dosed Every Three Weeks Achieved and Maintained Target Hemoglobin Levels in Patients With Chemotherapy-Induced Anemia
- The Effect of Bosentan on Matrix Metalloproteinase-9 Levels in Patients With Systemic Sclerosis-Induced Pulmonary Hypertension
 |
 |
User Comments (0)
RSS Feeds